Remove Labelling Remove Packaging Remove Vaccines
article thumbnail

Effective Control of Microorganisms in Pharmaceutical Manufacturing

GMPSOP

In manufacturing environments where living cells are used, such as biological products like vaccines, manufacturers generally include a virus reduction step in their processes. Bacteria and fungi also play important roles in the consumer and pharmaceutical industry, for instance, in the production of food, vaccines, and antibiotics.

article thumbnail

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. The regulatory agency has also given approval to the removal of the REMS requirement from the product labels. Credit: Saiful52 / Shutterstock.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PillPack from Amazon Pharmacy Expands to Medicare Part D: How PillPack and 24/7 Support Are Transforming Medication Access and Adherence

Pharmacy Times

What we've done is blend PillPack's innovative packaging with Amazon Pharmacy's user-friendly approach and affordability, so these patients can now get their medications in convenient, personalized packets and order everything online through our digital pharmacy. Subscribe Now!

article thumbnail

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Pharmacy Times

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 1-3 Detect-A-Dose Lid Label Covers. 1-3 Detect-A-Dose Lid Label Covers. Pharmacists must adapt to new tools, ensuring safe medication distribution through improved literacy and teamwork.

article thumbnail

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Pharmacy Times

Along with the successful pivotal trials, Launch-HTN and Advance-HTN, and the ongoing open-label extension trial, these results comprise the core package for our planned NDA submission.” Explore-CKD established that lorundrostat 25 mg once daily has a favorable clinical profile for this patient population.

article thumbnail

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

Pharmacy Times

It's cognitive behavioral therapy packaged as a digital experience. I've even seen VR experiences, so it can be packaged in any type of digital experience. Typically, it's a white-labeled experience, so it has the look and feel of that digital therapeutic throughout the entire experience.

article thumbnail

FDA approves KalVista’s Ekterly for hereditary angioedema

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? The positive results from the KONFIDENT trial were further supported by findings from the real-world KONFIDENT-S open-label extension study. Ekterly has the potential to become the foundational treatment for HAE and our focus now is on delivering it to the people who need it.”

Packaging 122